Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor

Fibroblast growth factor receptor (FGFR) is associated with proliferation, migration, and angiogenesis of carcinomas, and FGFR signaling inhibitors are considered a key drug for the treatment of solid tumors with FGFR overexpression. Amplification of FGFR2 is reportedly identified in 3%‐10% of gastr...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Sci
Главные авторы: Kuroda, Kenji, Yashiro, Masakazu, Miki, Yuichiro, Sera, Tomohiro, Yamamoto, Yurie, Sugimoto, Atsushi, Nishimura, Sadaaki, Kushiyama, Shuhei, Togano, Shingo, Okuno, Tomohisa, Ohira, Masaichi
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2020
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7734156/
https://ncbi.nlm.nih.gov/pubmed/32946655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14654
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы